Basic provera Information

• INN (International Nonproprietary Name): Medroxyprogesterone acetate
• Brand Names Available In Canada (English): Provera (various generics)
• ATC Code: G03DA02
• Forms & Dosages: Oral tablets 2.5 mg, 5 mg, 10 mg; injectable depot forms 104 mg (Depo‑SubQ) and 150 mg/mL (Depo‑Provera) in prefilled syringes or vials
• Manufacturers In Canada (English): Pfizer Inc. listed as a primary global supplier; various generic manufacturers supply Provera generics (specific Canadian manufacturers not specified)
• Registration Status In Canada (English): Provera is noted as available in Europe and Canada as Provera generics; specific Health Canada registration numbers or DINs are not specified in the supplied data
• OTC / Rx Classification: Prescription only (Rx)

Is Provera safe to start at home and how should it fit into daily life?

Provera (medroxyprogesterone acetate) is prescription-only in Canada and should only be used after a prescriber visit and pharmacist verification of the product DIN.

Do not start Provera if pregnancy is suspected, or if there is active thromboembolic disease, unexplained vaginal bleeding, known breast or genital cancer, or significant liver impairment.

For injectable contraception (Depo‑Provera or Depo‑SubQ Provera 104), expect dosing every 12 to 13 weeks and counselling about return-to-fertility and bone health.

Store oral tablets at or below 25–30°C and injectables at 15–30°C, protecting injectables from light.

Carry provincial medication coverage details (Ontario Drug Benefit, BC PharmaCare, RAMQ) when filling prescriptions and have a list of local pharmacies such as Shoppers Drug Mart, Rexall, Jean Coutu, and London Drugs for refills.

Rural patients may need extra planning or use accredited online pharmacies; always confirm DIN with the dispensing pharmacist before use.

Everyday Use & Best Practices

Morning Versus Evening Dosing In Canadian Routines

Which time of day fits best depends on work, transit, and personal routine.

Oral Provera tablets are available in 2.5 mg, 5 mg, and 10 mg strengths and should be taken at a consistent time daily to build a habit.

Morning with breakfast works well for commuters and people taking other morning medications.

Evening after supper suits shift workers or those with busy mornings.

For cyclical regimens, set phone reminders and mark the provincial patient portal or a paper calendar for the start and stop days.

For depot injections (Depo‑Provera 150 mg IM or Depo‑SubQ Provera 104 mg SQ), schedule clinic visits ahead and ask the clinic or pharmacy for reminder calls or texts.

Taking With Or Without Meals (Canadian Diet Context)

Provera may be taken with or without food.

Taking tablets with a meal often reduces nausea, which can help after heavier Canadian comfort meals.

Hydration helps with general tolerability and may reduce dizziness after injections for those who experience it.

Avoid large alcoholic binges within 24–48 hours of an injection if dizziness or drowsiness occurs.

• Checklist: Choose a daily time and set a phone alarm.
• Checklist: Mark cycle days in a paper calendar or provincial patient portal for cyclical regimens starting on day 16 or 21 as instructed.
• Checklist: Schedule injection appointments 11–12 weeks out and confirm next-visit reminders with clinic or pharmacy.

Keywords naturally used: Provera tablets, medroxyprogesterone acetate, Provera 5 mg, Depo‑Provera.

Safety Priorities

Who Should Avoid It (Health Canada Advisories)

Who should not take Provera follows the product monograph and common regulatory advisories.

Avoid use in people with a history of deep vein thrombosis, pulmonary embolism, or stroke.

Do not use if there is diagnosed or suspected breast or genital cancer, undiagnosed vaginal bleeding, or significant liver disease.

A known allergy to medroxyprogesterone acetate or excipients is an absolute contraindication.

Use caution and close monitoring for those with a history of severe depression, migraine with aura, uncontrolled hypertension, diabetes with vascular disease, epilepsy, or high risk of osteoporosis.

Activities To Limit (Driving, Workplace Safety)

Monitor for drowsiness, dizziness, or mood changes after starting Provera.

Avoid driving or operating heavy machinery until individual reactions are known.

In workplace safety settings such as construction or transport, notify occupational health if there are new concentration or balance issues after starting therapy.

• Monitoring Checklist: Baseline blood pressure measurement before starting.
• Monitoring Checklist: Baseline weight and periodic weight checks.
• Monitoring Checklist: Mood screening, particularly with history of depression.
• Monitoring Checklist: Bone health discussion for users of long-term injectable MPA; consider DEXA if Depo‑Provera use exceeds 2 years.

Keywords naturally used: contraindications Provera, medroxyprogesterone safety, Depo‑Provera warnings.

Dosage & Adjustments

General Regimen (DIN References)

Standard oral dosing for menstrual disorders is commonly 5 or 10 mg daily for 5–10 days, often started on day 16 or day 21 of the cycle.

For endometrial protection with estrogen in postmenopausal HRT, 5–10 mg daily for 12–14 days each month is typical.

Injectable contraception is Depo‑Provera 150 mg IM every three months or Depo‑SubQ Provera 104 mg SQ every three months.

Always confirm the product DIN and exact strength with the dispensing pharmacist before leaving the pharmacy.

Special Cases (Elderly, Comorbidities)

Children: not routinely approved; specialist guidance required for pediatric cases.

Elderly patients: no routine dose change, but weigh thromboembolic and dementia risks and monitor closely.

Liver impairment: contraindicated in significant hepatic dysfunction because medroxyprogesterone acetate is hepatically metabolized.

Renal disease: no routine adjustment noted, but comorbid renal disease requires careful monitoring.

Missed oral dose: take the same day if remembered; do not double doses.

Missed injection: get the injection as soon as possible and use backup contraception if delayed.

Keywords naturally used: Provera dosing, medroxyprogesterone dosage, Depo‑SubQ Provera 104.

User Testimonials

Positive Reports From Canadian Patients

Many Canadians report that short oral courses of Provera control heavy or irregular bleeding effectively.

Several people find the three-month injectable reliable and convenient for contraception.

Urban users often mention easy refill cycles through pharmacy chains and helpful pharmacist counselling about side effects and storage.

Common Challenges In Forums

Forum discussions report irregular spotting during the first one to three cycles with oral or injectable regimens.

Weight concerns and mood swings are common topics on Reddit Canada and provincial health boards.

Injectable users frequently mention delayed return to fertility, sometimes lasting several months.

Rural users report access barriers for timely injections and occasional travel to community health centres for administration.

• Pros Checklist: Effective for heavy bleeding; reliable contraception for three months with injectables.
• Cons Checklist: Initial spotting, possible weight change, mood changes, delayed fertility after injectables.
• Patient Tip: Keep a symptom diary tracking bleeding, mood, and weight for follow-up visits.

Keywords naturally used: Provera reviews Canada, Depo‑Provera experiences, medroxyprogesterone side effects.

Buying Guide

Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)

Provera is prescription-only and should be dispensed by licensed Canadian pharmacies such as Shoppers Drug Mart, Rexall, Jean Coutu, or London Drugs.

Injectables may be administered at public health clinics, sexual health centres, or by community nurses and hospital outpatient pharmacies.

Ask the pharmacist for the DIN and compare brand versus generic pricing when the prescription is filled.

Price Comparison (In-Store Vs Online, Cross-Border Notes)

Provincial plans such as Ontario Drug Benefit, BC PharmaCare, and RAMQ may cover Provera for eligible patients; private insurance may require prior authorization.

Generics are often less expensive than brand-name tablets.

Online pharmacies should be licensed Canadian e‑pharmacies; cross-border purchases can face import restrictions and are not recommended without verification.

In our online pharmacy, provera is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Keywords naturally used: buy Provera Canada, Provera price, DIN Provera.

What’s Inside & How It Works

Ingredients Overview

The active ingredient is medroxyprogesterone acetate, commonly abbreviated MPA.

Tablet strengths include 2.5 mg, 5 mg, and 10 mg in many international markets.

Injectable contraceptives are typically Depo‑Provera 150 mg/mL or Depo‑SubQ Provera 104 mg/0.65 mL in prefilled syringes or vials.

Excipients vary by manufacturer; consult the pharmacist if allergies to tablet excipients are a concern.

Mechanism Basics

MPA is a synthetic progestogen that stabilizes the endometrium during oral cyclical use and causes withdrawal bleeding on stopping.

For injectable contraception, MPA suppresses ovulation and thickens cervical mucus, providing contraception for approximately 12–13 weeks.

Effectiveness depends on correct timing for oral cycles and timely injections for depot contraception.

Injectable users should be counselled on the potential for delayed return to fertility after stopping injections.

Keywords naturally used: medroxyprogesterone acetate, Provera tablets, Depo‑Provera mechanism.

Main Indications

Approved Uses In Canada

Provera is used for menstrual disorders such as secondary amenorrhea and abnormal uterine bleeding.

It is also used as the progestogen component in hormone replacement therapy to protect the endometrium when estrogen is prescribed.

Depot preparations such as Depo‑Provera and Depo‑SubQ are approved contraceptives providing three-month protection.

Off-Label Uses By Canadian Physicians

Off-label uses include short-term management of endometriosis-related bleeding and suppression of irregular bleeding in some endocrine disorders.

Specialist clinicians may individualize timing and dose for complex menstrual disorders, and these decisions should be documented in the medical record.

Patients should keep a copy of their prescription and request the product monograph from the pharmacist for reference.

Keywords naturally used: Provera indications Canada, medroxyprogesterone uses, Depo‑Provera contraception.

Interaction Warnings

Food Interactions (Alcohol, Caffeine)

There are no major food interactions with Provera, and tablets can be taken with or without food.

Taking tablets with food may reduce nausea.

Alcohol can worsen mood changes, drowsiness, and may contribute to weight gain, so moderation is advised.

Caffeine has no known clinically important interaction with medroxyprogesterone acetate, but watch for sleep or anxiety effects if mood symptoms occur.

Drug Conflicts (Health Canada Database)

Medroxyprogesterone acetate is metabolized by the liver and enzyme inducers can reduce circulating progestogen levels.

Common offenders include certain anticonvulsants, rifampin, and herbal inducers such as St. John’s Wort.

When enzyme-inducing drugs are started, discuss alternative contraception or additional precautions with the prescriber and pharmacist.

Practical step: Provide the pharmacist with a full medicines list including OTCs and natural products.

Keywords naturally used: Provera interactions, medroxyprogesterone drug interactions, Depo‑Provera cautions.

Latest Evidence & Insights

Canadian Studies And Guidance (Summaries)

Canadian guidance generally aligns with international product monographs and supports Provera for menstrual control and MPA depot contraception.

Canadian literature emphasizes bone density consideration for long-term Depo‑Provera users and counselling on delayed return to fertility.

Provincial policies stress documentation of DIN and follow-up care for patients on depot contraception.

International Research & Practice Points

Systematic reviews show that short courses of 5–10 mg daily are effective for abnormal uterine bleeding.

Injectable MPA is highly effective for contraception but is associated with potential weight gain and amenorrhea.

Safety signals to watch include bone density loss with prolonged depot use and typical thromboembolic risks associated with progestogen therapy in susceptible patients.

Keywords naturally used: Provera evidence, medroxyprogesterone research, Depo‑Provera studies.

Alternative Choices

Comparable Medicines (Pros/Cons)

Alternatives to Provera include norethindrone acetate (Aygestin), micronized progesterone (Prometrium), drospirenone, and levonorgestrel options.

Levonorgestrel IUDs offer localized progestin with lower systemic exposure and are useful for long-term contraception and heavy bleeding control.

Oral progestins provide flexible dosing and easy discontinuation, while injectables reduce daily adherence burden but may delay fertility return.

How To Choose (Patient Checklist)

Decide based on medical history, fertility goals, preferences about monthly versus long-acting methods, and bone health risk.

Consider provincial coverage, clinic access for injections, and whether mood or weight changes are a major concern.

Keywords naturally used: alternatives to Provera, norethindrone acetate, micronized progesterone.

Regulation Snapshot

Health Canada Approval & DIN Requirements

Products for medroxyprogesterone acetate must be approved and carry a Drug Identification Number (DIN) to be lawfully dispensed in Canada.

Always verify the DIN printed on the package and the pharmacy label when filling a prescription.

Pharmacists are required to confirm prescriber authorization before dispensing Rx medications.

Provincial Coverage & Dispensing Rules

Provincial formularies differ and may list Provera under specific criteria for age or indication.

Examples include Ontario Drug Benefit, BC PharmaCare, and RAMQ in Quebec, each with their own listing and prior authorization rules.

Injectable administration may be offered through public health programs or covered with an administration fee at private pharmacies.

• Patient Checklist: Bring provincial health card, prescription, and ask pharmacist for DIN for adjudication.
• Patient Checklist: Ask whether the injection administration fee is covered by the provincial program or private insurance.

Keywords naturally used: Health Canada Provera, DIN Provera, provincial drug plans.

FAQ Section

Will Provera Make Me Gain Weight?

Some users, particularly with injectable MPA, report weight gain.

Monitor diet and exercise while on therapy and discuss alternatives if weight change is a major concern.

How Soon Will My Periods Normalise After Stopping?

With short oral cyclical use, a withdrawal bleed usually occurs after stopping and cycles often normalise over a few months.

After an injection, ovulation and regular periods can be delayed for several months and sometimes longer than a year in individual cases.

Can I Get Provera Covered By My Provincial Plan?

Coverage depends on the provincial formulary and patient eligibility.

Provide the pharmacist with your provincial health information and the DIN to check coverage with Ontario Drug Benefit, BC PharmaCare, or RAMQ.

Is Depo‑Provera Reversible For Pregnancy Plans?

Depo‑Provera is reversible; however, fertility may return slowly and planning should account for possible delay.

• Step: Keep a symptom and bleeding diary to discuss with your prescriber.
• Step: Ask the pharmacist to provide the DIN for insurance adjudication.
• Step: Plan contraception changes well ahead if pregnancy is desired in the near future.

Keywords naturally used: Provera FAQ Canada, Depo‑Provera fertility, Provera weight gain.

Guidelines For Proper Use

Pharmacist Counselling Points (Short Checklist)

Confirm the indication and record the DIN on the patient record.

Review absolute contraindications including thromboembolism, breast/genital cancer, significant liver disease, and hypersensitivity.

Check current medications for enzyme inducers and advise on backup contraception if needed.

Explain dosing schedules for oral versus injectable options and demonstrate missed-dose actions.

Discuss common side effects: irregular bleeding, mood changes, weight change, and injection-site reactions.

Advise on storage: tablets at ≤25–30°C; injectables at 15–30°C and protected from light.

Provincial Health Authority Recommendations (Follow-Up)

Schedule injection appointments every 12–13 weeks for depot contraception and obtain baseline blood pressure and weight.

For Depo‑Provera users with anticipated long-term use (>2 years), discuss bone health assessment and consider DEXA scanning as appropriate.

Plan logistical support for rural patients who may need travel or community clinic appointments for injections.

Keywords naturally used: Provera counselling, medroxyprogesterone follow up, Depo‑Provera monitoring.

Delivery Across Canada (English)